This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2022 Apr;62(4):916-918.

doi: 10.1111/trf.16825.

Alloimmunization rates in transfused patients receiving anti-CD47 antibody therapy

Timothy Carll¹, Zhen Mei², Fatima Aldarweesh¹, Geoffrey D Wool¹

Affiliations

Affiliations

¹ Department of Pathology, University of Chicago, Chicago, Illinois, USA.
² Department of Pathology, University of California - Los Angeles, Los Angeles, California, USA.

PMID: 35383955
DOI: 10.1111/trf.16825

Alloimmunization rates in transfused patients receiving anti-CD47 antibody therapy

Timothy Carll et al. Transfusion. 2022 Apr.

. 2022 Apr;62(4):916-918.

doi: 10.1111/trf.16825.

Authors

Timothy Carll¹, Zhen Mei², Fatima Aldarweesh¹, Geoffrey D Wool¹

Affiliations

¹ Department of Pathology, University of Chicago, Chicago, Illinois, USA.
² Department of Pathology, University of California - Los Angeles, Los Angeles, California, USA.

PMID: 35383955
DOI: 10.1111/trf.16825

No abstract available

PubMed Disclaimer

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Research Materials
- NCI CPTC Antibody Characterization Program